JP2016515624A5 - - Google Patents

Download PDF

Info

Publication number
JP2016515624A5
JP2016515624A5 JP2016506615A JP2016506615A JP2016515624A5 JP 2016515624 A5 JP2016515624 A5 JP 2016515624A5 JP 2016506615 A JP2016506615 A JP 2016506615A JP 2016506615 A JP2016506615 A JP 2016506615A JP 2016515624 A5 JP2016515624 A5 JP 2016515624A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
value
less
ion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016506615A
Other languages
English (en)
Japanese (ja)
Other versions
JP6280636B2 (ja
JP2016515624A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/032815 external-priority patent/WO2014165670A1/en
Publication of JP2016515624A publication Critical patent/JP2016515624A/ja
Publication of JP2016515624A5 publication Critical patent/JP2016515624A5/ja
Application granted granted Critical
Publication of JP6280636B2 publication Critical patent/JP6280636B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016506615A 2013-04-05 2014-04-03 カリウムの低減と慢性腎臓病及び/または慢性心臓病の治療のための微多孔性ケイ酸ジルコニウム及び利尿剤 Active JP6280636B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
US201361808897P 2013-04-05 2013-04-05
US61/808,897 2013-04-05
US201361914362P 2013-12-10 2013-12-10
US61/914,362 2013-12-10
US201461930331P 2014-01-22 2014-01-22
US61/930,331 2014-01-22
PCT/US2014/032815 WO2014165670A1 (en) 2013-04-05 2014-04-03 Microporous zirconium silicate and diuretics for the reduction of potassium and treatment of chronic kidney and/or chronic heart disease

Publications (3)

Publication Number Publication Date
JP2016515624A JP2016515624A (ja) 2016-05-30
JP2016515624A5 true JP2016515624A5 (cg-RX-API-DMAC7.html) 2017-04-13
JP6280636B2 JP6280636B2 (ja) 2018-02-14

Family

ID=51654632

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016506615A Active JP6280636B2 (ja) 2013-04-05 2014-04-03 カリウムの低減と慢性腎臓病及び/または慢性心臓病の治療のための微多孔性ケイ酸ジルコニウム及び利尿剤

Country Status (21)

Country Link
US (3) US20160051584A1 (cg-RX-API-DMAC7.html)
EP (1) EP2981272B1 (cg-RX-API-DMAC7.html)
JP (1) JP6280636B2 (cg-RX-API-DMAC7.html)
KR (1) KR102308673B1 (cg-RX-API-DMAC7.html)
CN (1) CN105473151B (cg-RX-API-DMAC7.html)
AU (1) AU2014248081B2 (cg-RX-API-DMAC7.html)
BR (1) BR112015025438B1 (cg-RX-API-DMAC7.html)
CA (1) CA2908641C (cg-RX-API-DMAC7.html)
CL (1) CL2015002951A1 (cg-RX-API-DMAC7.html)
DK (1) DK2981272T3 (cg-RX-API-DMAC7.html)
ES (1) ES2943007T3 (cg-RX-API-DMAC7.html)
FI (1) FI2981272T3 (cg-RX-API-DMAC7.html)
HU (1) HUE061862T2 (cg-RX-API-DMAC7.html)
IL (1) IL241926B (cg-RX-API-DMAC7.html)
MX (1) MX2015014055A (cg-RX-API-DMAC7.html)
PH (1) PH12015502301A1 (cg-RX-API-DMAC7.html)
PL (1) PL2981272T3 (cg-RX-API-DMAC7.html)
PT (1) PT2981272T (cg-RX-API-DMAC7.html)
TW (1) TW201521746A (cg-RX-API-DMAC7.html)
WO (1) WO2014165670A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201507666B (cg-RX-API-DMAC7.html)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109106725A (zh) 2011-02-11 2019-01-01 Zs制药公司 用于治疗高钾血症的微孔性的硅酸锆
US9592253B1 (en) * 2015-10-14 2017-03-14 ZS Pharma, Inc. Extended use zirconium silicate compositions and methods of use thereof
CN114917247B (zh) * 2022-05-18 2024-01-26 广东省疾病预防控制中心 纳米二氧化钛在防治肾损伤中的应用
CN117776193A (zh) * 2023-12-25 2024-03-29 杭州国瑞生物科技有限公司 一种环硅酸锆钠zs-9的制备方法及其应用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601398D0 (en) * 1996-01-24 1996-03-27 Piper Edwina M Composition
US5888472A (en) 1997-04-08 1999-03-30 Uop Llc Zirconium silicate molecular sieves and process using the same
US5891417A (en) 1997-04-08 1999-04-06 Uop Llc Zirconium silicate and zirconium germanate molecular sieves and process using the same
US6099737A (en) 1999-03-29 2000-08-08 Uop Llc Process for removing toxins from blood using zirconium metallate or titanium metallate compositions
US6332985B1 (en) 1999-03-29 2001-12-25 Uop Llc Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions
AU2000260501A1 (en) * 2000-07-12 2002-01-21 Uop Llc Process for removing toxins from bodily fluids using zirconium or titanium microporous compositions
US20040105895A1 (en) * 2001-02-06 2004-06-03 Ash Stephen R Monovalent-selective cation exchangers as oral sorbent therapy
US6579460B1 (en) * 2001-03-13 2003-06-17 Uop Llc Process and composition for removing toxins from bodily fluids
WO2010022381A1 (en) 2008-08-22 2010-02-25 Relypsa, Inc. Treating hyperkalemia with crosslinked cation exchange polymers of improved physical properties
ES2939021T3 (es) * 2008-08-22 2023-04-18 Vifor Int Ltd Composiciones que comprenden polímeros reticulados de intercambio catiónico y uso en el tratamiento de la hipercalemia
US20120070468A1 (en) * 2010-09-16 2012-03-22 Uop Llc Removal of toxins from gastrointestinal fluids
CN109106725A (zh) 2011-02-11 2019-01-01 Zs制药公司 用于治疗高钾血症的微孔性的硅酸锆
AU2013290141A1 (en) 2012-07-11 2015-02-05 Alvaro F. Guillem Microporous zirconium silicate for the treatment of hyperkalemia in hypercalcemic patients and improved calcium-containing compositions for the treatment of hyperkalemia
CN104797263B (zh) * 2012-10-22 2018-02-09 Zs制药公司 用于治疗高钾血症的微孔硅酸锆

Similar Documents

Publication Publication Date Title
FI2673237T4 (fi) Zirkoniumsilikaatin käyttö hyperkalemian hoitamiseen
JP2016515624A5 (cg-RX-API-DMAC7.html)
Ferrari RAAS inhibition and mortality in hypertension
JP2010174019A5 (cg-RX-API-DMAC7.html)
JP2020508339A5 (cg-RX-API-DMAC7.html)
RU2017106756A (ru) Композиция для контролируемой стимуляции яичников
JP2016512248A5 (cg-RX-API-DMAC7.html)
JP2014513089A5 (cg-RX-API-DMAC7.html)
JP2016065086A5 (cg-RX-API-DMAC7.html)
JP2014114295A5 (cg-RX-API-DMAC7.html)
JP2013516442A5 (cg-RX-API-DMAC7.html)
MY194850A (en) (2s)-n-[(1s)-1-cyano-2-phenylethyl]-1,4-oxazepane-2-carboxamides as dipeptidyl peptidase i inhibitors
JP2015500225A5 (cg-RX-API-DMAC7.html)
JP2015505564A5 (cg-RX-API-DMAC7.html)
RU2013121788A (ru) Ингибиторы репликации вич
JP2014516942A5 (cg-RX-API-DMAC7.html)
JP2019503387A5 (cg-RX-API-DMAC7.html)
JP2014527040A5 (cg-RX-API-DMAC7.html)
JP2012502909A5 (cg-RX-API-DMAC7.html)
JP2011527687A5 (cg-RX-API-DMAC7.html)
RU2015110979A (ru) Комбинации ингибиторов sglt 2 и антигипертензивных лекарственных средств
FI2981272T3 (fi) Mikrohuokoinen zirkoniumsilikaatti ja diureetteja kaliumin vähentämiseksi ja kroonisen munuais- ja/tai kroonisen sydänsairauden hoitamiseksi
RU2014104993A (ru) Кристаллическая форма натриевой соли 4-трет-бутил-n-{4-хлор-2-(1-окси-пиридин-4-карбонил)-фенил}-бензолсульфонамид
RU2016125659A (ru) Лекарственные средства для лечения заболеваний шейных позвонков и/или поясничных позвонков
JP2017106817A5 (cg-RX-API-DMAC7.html)